Wealthfront Advisers LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealthfront Advisers LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 44,686 shares of the medical equipment provider's stock after buying an additional 770 shares during the period. Wealthfront Advisers LLC's holdings in Intuitive Surgical were worth $22,132,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Castleark Management LLC boosted its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock worth $47,221,000 after buying an additional 2,990 shares during the period. Arlington Trust Co LLC boosted its position in Intuitive Surgical by 34.5% during the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aaron Wealth Advisors LLC boosted its position in Intuitive Surgical by 3.2% during the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after purchasing an additional 78 shares during the last quarter. Ewing Morris & Co. Investment Partners Ltd. acquired a new stake in Intuitive Surgical during the fourth quarter valued at $454,000. Finally, Whalerock Point Partners LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at $209,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $4.21 during mid-day trading on Tuesday, reaching $512.23. The stock had a trading volume of 1,673,183 shares, compared to its average volume of 1,684,092. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00. The stock's 50-day simple moving average is $537.54 and its 200-day simple moving average is $536.54. The firm has a market capitalization of $183.59 billion, a PE ratio of 75.11, a price-to-earnings-growth ratio of 5.48 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same period in the prior year, the firm posted $1.50 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. 0.70% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial reduced their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Evercore ISI lifted their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $592.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.